Trigen Pharma | Microcirculation Center

TriCardin

TriCardin is the only medicine in the world that treats the entire cardiovascular system and is used as the first line of treatment.

Tasly Microcirculation Research Center at Peking University (China)

Tasly-Peking University Microcirculation Center is a research institute under the School of Fundamental Medicine, Peking University co-founded by Tasly and Peking University Health Science Center (PUHSC) in September 2004. It was officially recognized in September 2009 as a grade-three microcirculatory lab, and selected by the State Administration of Traditional Chinese Medicine as one of the key phlegm stasis labs in December 2012.

Headed by Prof. Han Jingyan, Dean of the Department of Integrative Medicine, PUHSC, the Microcirculation Center, through cooperation with the Department of Cardiology, PUHSC First Clinical Hospital, established Beijing Microangiopathy Research Office of Integrative Medicine in February 2014.

The Microcirculation Center consists of a visualized organic microcirculation research system (including an organic microcirculation office), a microvascular histology and histochemistry research system (including histology and histochemistry office, ultramicrostructure office and laser confocal office), and a microvascular cytobiology and molecular biology research system (including cytobiology office and molecular biology office).

Dedicated to studies with respect to the theories on blood stasis, phlegm stasis as well as stimulation of circulation and removal of stasis, the Microcirculation Center engages in studies of the mechanism of blood and phlegm stasis due to various factors, and the physical foundation and working mechanism of Chinese combination drug relieving blood and phlegm stasis, and proposes new drugs while clarifying the scientific connotations of the above theories.

The Microcirculation Center, together with Tasly, has completed international cooperation projects sponsored by the Ministry of Science and Technology, sub-projects of Significant New Drug Development Projects, projects sponsored by the National Natural Science Foundation and studies entrusted by enterprises. Besides, it has obtained over 20 invention patents and published more than 50 papers and reviews, which have been included by SCI. Among them, Ameliorating effects of compounds derived from salvia miltiorrhiza root extract on microcirculatory disturbance and target-organ injury by ischemia-reperfusion (Pharmacology and Therapeutics. 2008,117:280-295) was listed in China Top 100 Academic Papers of International Influence 2008.

With a staff of interdisciplinary researchers and technicians at multiple levels in TCM, integrative medicine, clinical medicine, pharmacology and biology, the center has coached 17 masters, 34 doctors and 3 postdocs. The center provides post-doctoral education.

The Microcirculation Center has established partnership with Keio University, Toyama University, Kitasato University, the National Center for Child Health and Development of Japan, Cambridge University, School of Chinese Medicine of the University of Hong Kong, School of Chinese Medicine of Hong Kong Baptist University, research offices of 15 domestic universities, Peking University Health Science Center, and 22 research offices at the headquarters.

The Microcirculation Center is affiliated to the Professional Board of Microcirculation, Chinese Association of Integrative Medicine, the Professional Board of Phlegm Stasis, Chinese Society of Microcirculation, and the Professional Board of Qi and Blood, World Federation of Chinese Medicine Societies. Prof. Han Jingyan is executive member at the International Microcirculation Federation, vice chairman at the Chinese Society of Microcirculation, chief councilor at the Professional Board of Phlegm Stasis, Chinese Society of Microcirculation, director at the Chinese Association of Integrative Medicine and chief councilor at the Professional Board of Microcirculation, executive member at the World Federation of Chinese Medicine Societies and director-general at the Professional Board of Qi and Blood, vice chairman at the Professional Board of Chinese Pharmacology, deputy chief councilor at the Professional Board of Microcirculation, Chinese Association of Pathophysiology, director at the Chinese Pharmaceutical Association and deputy chief councilor at the Professional Board of Senile Pharmacy, deputy chief councilor at the Sub-association of Doctoral Research, China Association of Chinese Medicine, secretary-general at Japan Association of Clinical Chinese Medicine, councilor at Japan Microcirculation Society, deputy chief editor at the Microcirculation magazine (2010-2013), chief editor at WJTCM and deputy chief editor at World Chinese Medicine.